Spending $24 billion to develop prototype vaccines for the 26 known viral families is a proactive and essential investment in public health. By preparing in advance, we can significantly reduce the time needed to respond to future pandemics, ultimately saving countless lives and reducing the economic impact of outbreaks. Foreseeing potential threats and being prepared is key to global health security.